INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 139 filers reported holding INTERSECT ENT INC in Q4 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $647,000 | +20.0% | 25,977 | +9.7% | 0.03% | +3.2% |
| Q2 2019 | $539,000 | +1.5% | 23,677 | +25.5% | 0.03% | -8.8% |
| Q4 2018 | $531,000 | -58.9% | 18,860 | -58.1% | 0.03% | -42.4% |
| Q3 2018 | $1,292,000 | +27.0% | 44,963 | +65.5% | 0.06% | +43.9% |
| Q2 2018 | $1,017,000 | +27.9% | 27,163 | +34.2% | 0.04% | +28.1% |
| Q1 2018 | $795,000 | -42.8% | 20,242 | -52.9% | 0.03% | -48.4% |
| Q4 2017 | $1,391,000 | -41.9% | 42,942 | -44.1% | 0.06% | -49.2% |
| Q3 2017 | $2,393,000 | +145.7% | 76,842 | +120.4% | 0.12% | +134.6% |
| Q2 2017 | $974,000 | +274.6% | 34,864 | +129.4% | 0.05% | +333.3% |
| Q1 2017 | $260,000 | -26.3% | 15,200 | -47.9% | 0.01% | -42.9% |
| Q4 2016 | $353,000 | +57.6% | 29,200 | +68.1% | 0.02% | +90.9% |
| Q2 2016 | $224,000 | -53.1% | 17,372 | -31.0% | 0.01% | -47.6% |
| Q1 2016 | $478,000 | +30.6% | 25,172 | +60.8% | 0.02% | +50.0% |
| Q3 2015 | $366,000 | -32.6% | 15,659 | -17.5% | 0.01% | -22.2% |
| Q2 2015 | $543,000 | – | 18,990 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 238,698 | $3,781,000 | 3.74% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $4,356,000 | 1.32% |
| Broadfin Capital, LLC | 638,600 | $10,115,000 | 0.91% |
| Aisling Capital LLC | 248,498 | $3,936,000 | 0.81% |
| Bellevue Group AG | 205,325 | $3,252,000 | 0.59% |
| Iguana Healthcare Management, LLC | 180,000 | $2,852,000 | 0.51% |
| Rock Springs Capital Management LP | 345,000 | $5,465,000 | 0.34% |
| SECTORAL ASSET MANAGEMENT INC | 168,140 | $2,663,000 | 0.26% |
| FORMULA GROWTH LTD | 62,213 | $985,000 | 0.22% |
| MENTA CAPITAL LLC | 111,915 | $1,773,000 | 0.17% |